SI2313778T1 - Diagnostika za membransko nefropatijo - Google Patents

Diagnostika za membransko nefropatijo

Info

Publication number
SI2313778T1
SI2313778T1 SI200931173T SI200931173T SI2313778T1 SI 2313778 T1 SI2313778 T1 SI 2313778T1 SI 200931173 T SI200931173 T SI 200931173T SI 200931173 T SI200931173 T SI 200931173T SI 2313778 T1 SI2313778 T1 SI 2313778T1
Authority
SI
Slovenia
Prior art keywords
diagnostics
membranous nephropathy
membranous
nephropathy
Prior art date
Application number
SI200931173T
Other languages
English (en)
Inventor
David J. Salant
Laurence H. Beck
Gerard Lambeau
Original Assignee
Boston Medical Center Corporation
Centre National De La Recherche Scientifique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41226751&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2313778(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boston Medical Center Corporation, Centre National De La Recherche Scientifique filed Critical Boston Medical Center Corporation
Publication of SI2313778T1 publication Critical patent/SI2313778T1/sl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/918—Carboxylic ester hydrolases (3.1.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
SI200931173T 2008-07-18 2009-07-20 Diagnostika za membransko nefropatijo SI2313778T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8178608P 2008-07-18 2008-07-18
PCT/US2009/051110 WO2010009457A1 (en) 2008-07-18 2009-07-20 Diagnostics for membranous nephropathy
EP09790621.8A EP2313778B1 (en) 2008-07-18 2009-07-20 Diagnostics for membranous nephropathy

Publications (1)

Publication Number Publication Date
SI2313778T1 true SI2313778T1 (sl) 2015-06-30

Family

ID=41226751

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200931173T SI2313778T1 (sl) 2008-07-18 2009-07-20 Diagnostika za membransko nefropatijo

Country Status (10)

Country Link
US (2) US8507215B2 (sl)
EP (1) EP2313778B1 (sl)
JP (1) JP5453420B2 (sl)
KR (1) KR101643783B1 (sl)
CN (1) CN102159951B (sl)
CA (2) CA2731065C (sl)
DK (1) DK2313778T3 (sl)
ES (1) ES2535640T3 (sl)
SI (1) SI2313778T1 (sl)
WO (1) WO2010009457A1 (sl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2313778B1 (en) * 2008-07-18 2015-01-28 Boston Medical Center Corporation Diagnostics for membranous nephropathy
US8956859B1 (en) 2010-08-13 2015-02-17 Aviex Technologies Llc Compositions and methods for determining successful immunization by one or more vaccines
GB201410108D0 (en) * 2014-06-06 2014-07-23 Univ Manchester Peptides, and methods and apparatus utilising same
WO2016009971A1 (ja) * 2014-07-14 2016-01-21 国立大学法人名古屋大学 抗ホスホリパーゼａ２レセプター抗体の簡易測定
EP2977758A1 (en) * 2014-07-24 2016-01-27 Université De Nice Sophia Antipolis Methods and kits for monitoring membranous nephropathy
CN104849452A (zh) * 2015-05-14 2015-08-19 深圳市伯劳特生物制品有限公司 一种pla2r抗体定量检测试纸条及制作、检测方法
CN104880560B (zh) * 2015-05-14 2017-04-12 深圳市伯劳特生物制品有限公司 一种pla2r抗体检测试纸条及制作、检测方法
US10989665B2 (en) * 2015-06-17 2021-04-27 Total Sa Method and solution for assaying inhibitors in a petroleum fluid containing water
KR20180072662A (ko) 2015-07-10 2018-06-29 추 드 니스 Pla2r1 에피토프 프로파일 및 확산의 분석을 기반으로 한 막성 신병증의 예후 및 모니터링
US11266717B2 (en) 2016-08-12 2022-03-08 Immunowork, Llc Diagnosis, prevention, and/or treatment of autoimmune diseases
CN109891241B (zh) * 2016-10-03 2022-12-06 秀比特生物技术公司 能够进行糖尿病性肾病的早期病情的特异性诊断的检查方法
JP6774091B2 (ja) * 2016-10-31 2020-10-21 国立大学法人 新潟大学 腎臓またはその各部の状態の判定方法およびそのためのキット
GB201717345D0 (en) * 2017-10-23 2017-12-06 Univ Manchester Peptides, methods and apparatus
CN108414478A (zh) * 2018-01-19 2018-08-17 祝胜郎 一种生物样品的检测方法
CN108414741B (zh) * 2018-01-19 2020-06-09 苏庆宁 一种免疫组合物在制备膜性肾病无创检测用试剂中的用途
CN109324043A (zh) * 2018-10-17 2019-02-12 睿诺医疗科技（上海）有限公司 一种用于肾病检测的试剂盒、及其制备和使用方法
CN109459572A (zh) * 2018-12-21 2019-03-12 江南大学 一种原发性膜性肾病诊断试剂盒
CN109557318A (zh) * 2019-01-31 2019-04-02 浙江理工大学 同时检测m型磷脂酶a2受体和１型血小板反应蛋白7a域自身抗体免疫层析条及检测卡
CN112195154B (zh) * 2019-07-08 2024-03-29 江苏汇智生物科技有限公司 一种基因改造表达改造型pla2r受体的细胞及其应用
WO2021023836A1 (en) * 2019-08-06 2021-02-11 Euroimmun Medizinische Labordiagnostika Ag An improved autoantibody detection assay
CN115176157A (zh) * 2020-06-29 2022-10-11 玛希隆大学 用于检测抗干扰素γ抗体的免疫层析方法及试剂盒
CN111781383A (zh) * 2020-07-24 2020-10-16 浙江理工大学绍兴生物医药研究院有限公司 检测M型磷脂酶A2受体IgG的免疫分析试剂盒及其检测方法
BR102021022687A2 (pt) 2020-12-11 2022-06-28 Euroimmun Medizinische Labordiagnostika Ag Método e reagentes para diagnosticar nefropatia membranosa
KR102548285B1 (ko) * 2021-02-10 2023-06-28 영남대학교 산학협력단 특발성 신증후군 진단용 바이오마커 조성물 및 이의 용도
WO2023172847A1 (en) * 2022-03-09 2023-09-14 Mayo Foundation For Medical Education And Research Methods and materials for identifying and treating membranous nephropathy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534431A (en) * 1994-02-28 1996-07-09 The Board Of Regents Of The University Of Nebraska Hybridomas and monoclonal antibodies specific for unique determinants of nephropathy-related immunoglobulin G and complexes thereof
JP4160263B2 (ja) * 1998-12-21 2008-10-01 モナッシュ ユニバーシティ 尿サンプル中の所定のタンパク質の全含有量を測定する方法
JP3924709B2 (ja) * 1999-01-22 2007-06-06 司甫 横山 測定試薬
JP2004286720A (ja) * 2003-03-19 2004-10-14 Morisuke Yokoyama 腎炎測定試薬
US20070281323A1 (en) * 2004-02-03 2007-12-06 Wolfert Robert L Methods Of Detecting Lp-PLA2 Activity
US20090312620A1 (en) * 2005-04-27 2009-12-17 Hou-Mei Henry Chang Diabetes monitor
CN101278059A (zh) * 2005-07-28 2008-10-01 肿瘤疗法科学股份有限公司 诊断和治疗肾细胞癌的方法
EP1882945A1 (en) * 2006-07-28 2008-01-30 F.Hoffmann-La Roche Ag Means and methods for the differentiation of cardiac and pulmonary causes of acute shortness of breath
WO2008060394A2 (en) * 2006-10-27 2008-05-22 Inova Diagnostics, Inc. Methods and assays for detecting gp73-specific autoantibodies
US20080166741A1 (en) * 2007-01-05 2008-07-10 Industrial Technology Research Institute Method for Diagnosing Membranous Glomerulonephritis Disease and a Kit Thereof
EP2313778B1 (en) * 2008-07-18 2015-01-28 Boston Medical Center Corporation Diagnostics for membranous nephropathy

Also Published As

Publication number Publication date
EP2313778A1 (en) 2011-04-27
CN102159951A (zh) 2011-08-17
US20110177534A1 (en) 2011-07-21
CN102159951B (zh) 2014-02-26
US8507215B2 (en) 2013-08-13
EP2313778B1 (en) 2015-01-28
DK2313778T3 (en) 2015-04-27
US20130280738A1 (en) 2013-10-24
ES2535640T3 (es) 2015-05-13
JP2011528789A (ja) 2011-11-24
CA2731065A1 (en) 2010-01-21
JP5453420B2 (ja) 2014-03-26
WO2010009457A1 (en) 2010-01-21
KR101643783B1 (ko) 2016-07-28
CA2731065C (en) 2018-09-18
KR20110033275A (ko) 2011-03-30
CA3013247A1 (en) 2010-01-21

Similar Documents

Publication Publication Date Title
SI2313778T1 (sl) Diagnostika za membransko nefropatijo
EP2497229A4 (en) USE OF OVERLAYS TO SECURE CONNECTIONS BETWEEN NETWORKS
GB2476424B (en) Ambiophonic headrest
ZA201109385B (en) Bace inhibitors
ZA201202299B (en) Method for decreasing immunigenicity
GB0906841D0 (en) Nanofiltration process
GB2480035B (en) Apparatus for providing connection between networks
GB0913229D0 (en) Apparatus for bio-automation
EP2283220A4 (en) DEVICE FOR MOTOR CONTROL
ZA201107480B (en) Apparatus for depositing
PL2174853T3 (pl) Krzesełko do wyciągu krzesełkowego
GB0914587D0 (en) Headrest
HK1169669A1 (en) Concatamers for immunemodulation
ZA201203155B (en) Method for isolating methylglycinenitrile-n,n-diacetonitrile
EP2585441A4 (en) PROCESS FOR OLMESARTAN MEDOXOMIL
GB2469272B (en) Block
GB0802036D0 (en) Device for forming
GB0906289D0 (en) Processes for making isoxazoline derivatives
GB201014083D0 (en) Apparatus for retaining
GB0821151D0 (en) Valve apparatus
GB0917844D0 (en) Chuck
AU4436P (en) Selexion Valerianella locusta
GR1007099B (en) Hoop-rolling means for entertainement purposes
AU323246S (en) Coffeemachine for coffeepods
HU0900501D0 (en) Valve for all purpose